...
首页> 外文期刊>Pediatric transplantation. >Clinical implication of renal allograft volume to recipient body surface area ratio in pediatric renal transplant
【24h】

Clinical implication of renal allograft volume to recipient body surface area ratio in pediatric renal transplant

机译:肾同种异体移植体积对儿科肾移植受体体表面积比的临床意义

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Our study aims to assess the clinical implication of RAV / rBSA ratio in PRT as a predictor for attained renal function at 1?year post‐transplantation and its association with surgical complications. A retrospective cohort was performed for PRT cases from January 2000 to December 2015 in our institution. Extracted clinical information includes the recipient's demographics, donor type, renal allograft characteristics, arterial, venous and ureteral anastomoses, vascular anastomosis time while kidney off ice, overall operative time, and estimated blood loss. The RAV / rBSA was extrapolated and assessed for its association with renal graft function attained in 1?year post‐transplantation and surgical complications within 30‐day post‐transplantation. A total of 324 PRT s cases were analyzed. The cohort consisted of 187 (52.4%) male and 137 (42.3%) female recipients, with 152 (46.9%) living donor and 172 (53.1%) deceased donor renal transplants, and an overall median age of 155.26?months (IQR 76.70‐186.98) at time of renal transplantation. The receiver operating characteristic identified that a RAV / rBSA ratio of 135 was the optimal cutoff in determining the renal graft function outcome. Univariate and multivariate analyses revealed the relative OR for RAV / rBSA ?≥?135 ratio in predicting an eGFR ?≥?90 attained within 1?year post‐transplant was highest among younger pediatric recipients (142.5?months) of deceased kidney donors ( OR ?=?11.143, 95% CI ?=?3.156‐39.34). Conversely, Kaplan‐Meier analysis revealed that RAV / rBSA ratio?≥?135 is associated with lower odds of having eGFR 60 ( OR ?=?0.417, 95% CI ?=?0.203‐0.856). The RAV / rBSA ratio was not associated nor predictive of transplant‐related surgical complications. Our study determined that the RAV / rBSA ratio is predictive of renal graft function at 1‐year PRT , but not associated with any increased surgical complications.
机译:摘要我们的研究旨在评估PRT在PRT中Rav / RBSA比的临床意义,作为在移植后1-岁及其与手术并发症的关系中获得肾功能的预测因素。追溯队列于2015年1月至2015年12月的PRT病例进行了备案。提取的临床信息包括受体的人口统计,供体类型,肾同种异体移植特征,动脉,静脉和输尿管吻合术,血管吻合时间,而肾脏脱离冰,整体手术时间和估计失血。 RAV / RBSA被推断并评估其与肾移植函数的关联,其在移植后30天内移植后和手术并发症。分析了324例PRT案例。队列由187名(52.4%)男性和137名(42.3%)女性受体组成,152名(46.9%)的活体供体和172名(53.1%)死者的供体肾移植,以及155.26岁的整体中位数(IQR 76.70 -186.98)在肾移植时。接收器操作特性确定了135的Rav / RBSA比率是确定肾移植函数结果时的最佳截止。单变量和多变量分析显示了相对或Rav / RBSA?≥?135比率在预测EGFR中的比率≥10℃?年龄在移植后的年龄患者中最高(& 142.5?月)死亡的肾脏捐赠者(或?=?11.143,95%CI?=?3.156-39.34)。相反,Kaplan-Meier分析显示Rav / RBSA比率Δ≥135与具有EGFR <60(或α= 0.417,95%CI = 0.203-0.856)的较低的几率较低。 Rav / RBSA比率未关联,也没有预测移植相关的外科并发症。我们的研究确定了Rav / RBSA比率在1年PRT的肾移植功能预测,但与任何增加的手术并发症无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号